A61F2250/0023

BRANCH POINT FLOW DIVERSION DEVICE
20220202558 · 2022-06-30 ·

A flow diversion device for the treatment of intracranial aneurysms and other medical conditions is disclosed. The flow diversion device may include a generally tubular wire stent frame formed from a plurality of zig-zag shaped wire elements that are coupled together. The device further includes a base layer of graft material coupled to the wire stent frame and surrounding at least a portion thereof, the wire stent frame maintaining the base layer in an open condition. In some embodiments, the base layer may be formed of porous graft material having a plurality of slits formed in the longitudinal direction. The slits may have a different shape in a compressed configuration and an expanded configuration. The slits provide a passageway for a small blood flow to maintain the long-term patency of important small side branches, while also reducing blood flow to the aneurysm to promote occlusion and avoid potential rupture.

ORBITAL FLOOR IMPLANT
20220202575 · 2022-06-30 ·

Embodiments of the present disclosure relate generally to an orbital floor implant (10). One embodiment provides an implant with a first surface that is a fully porous, bone-side layer (16) and a second surface that is a non-porous, orbital content-side layer (18). The implant material itself may be polymeric material throughout, without the need for an embedded mesh or other support matrix. The implant is provided in a pre-shaped configuration and is of a material that allows it to be bent for shaping purposes. An extending tab (12) with eyelet portion/opening (14) can enhance securement options to a patient's bone.

METHODS AND DEVICES FOR TREATING ILIOCAVAL COMPRESSION, OCCLUSION, REDUCTION OF VENOUS CALIBER, AND SYNDROMES AND DISEASE STATES RESULTING FROM OCCLUSION

Aspects of the invention provide a self-expanding stent device. The device comprises: an elongated body that defines a lumen within. The body has a first and a second terminus and a longitudinal axis located therebetween. The body comprises a first zone and a second zone along the longitudinal axis. When the device is in an expanded configuration the first zone has a first radial strength that is resistant to an external compressive force, and the second zone has a second radial strength that is resistant to an external compressive force. The radial strength of the first zone is greater than that of the second zone. The diameter of the body lumen proximal to the first terminus is greater than that of the lumen proximal to the second terminus.

Glaucoma treatment systems and methods

Glaucoma treatment devices are disclosed. In various example, the glaucoma treatment devices include a body and a fluid conduit that are configured to help facilitate evacuation of fluid from a fluid-filled body cavity, and reabsorption of the evacuated aqueous humor by the body through tissue surrounding the glaucoma treatment device. In some examples, the glaucoma treatment device is configured such that a flow resistance through the fluid conduit can be modified post-operatively one or more times.

LINER FOR PROSTHETIC AND ORTHOPEDIC SYSTEMS

A liner is arranged for use in prosthetic and orthopedic devices. The liner defines first and second end portions, and inner and outer surfaces. The liner includes an inner layer having a frictional component and forms at least part of the periphery of the inner liner surface. The inner layer defines a plurality of apertures. A porous element is in communication with the inner liner surface and is connected to the inner layer such that the apertures permit a transfer of air from the inner surface to the porous element. A base layer adjoins the porous element and extends between the first and second end portions of the liner.

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME
20220168468 · 2022-06-02 ·

Disclosed herein are devices for encapsulating biological cells and are suitable to be implanted into a subject. In different aspects of the disclosure, the devices may comprise a plurality of polymer layers. In one aspect, a device comprises a first polymer layer and a second polymer layer. In some cases, the first polymer layer may be a nanoporous polymer layer. In some cases, the second polymer layer may be a macroporous polymer layer. The first and second polymer layers may define a lumen for enclosing a population of cells. The devices may be used to transplant cells producing therapeutic agents into a subject (e.g., for the treatment of a disease).

CEREBRAL BLOOD FLOW REORGANIZATION
20220160527 · 2022-05-26 ·

An implantable device includes an outer tubular member defining a longitudinal axis and a lumen. The outer tubular member includes: an outer wall portion having a plurality of first strands defining a plurality of first openings therebetween, the outer wall portion having a first porosity; and an inner baffle portion disposed within the lumen, the inner baffle portion including a plurality of second strands defining a plurality of second openings therebetween, the inner baffle portion having a second porosity that is lower than the first porosity of the outer wall portion.

IMPLANTABLE COMPONENT WITH SOCKET
20230270548 · 2023-08-31 ·

Implantable devices may include a single, first component or a plurality of components such as first and second components, the second component being flexibly coupled to the first component. A socket extends over one or more of the component(s), the socket being configured to enhance the inter-component interaction and/or including one or more exposed surface(s) configured to exhibit one or more tiers of foreign body responses within a range of possible foreign body responses.

INTRAVASCULAR INDWELLING STENT

Disclosed is an intravascular indwelling stent that include a stent main body and a polymer film covering the stent main body. Through-holes are formed in the polymer film. The through-holes connect an inside and an outside of a cylinder of the intravascular indwelling stent to each other and each have an opening size of 0.02 mm or more and 0.2 mm or less. An opening occupancy, which is the ratio of the opening area of all the through-holes included in a unit area of the outer surface of the polymer film to the unit area, is 25% or more and 41% or less. A surface density of boundary, which is the ratio of the length of opening edges of all the through-holes included in a unit area of the outer surface of the polymer film to the unit area, is 9.5/mm or more and 30/mm or less.

FUSIFORM ANEURYSM TREATMENT
20220151806 · 2022-05-19 · ·

This specification is directed to stents that are configured to better deploy and remain implanted across a fusiform aneurysm. Specifically, these stents include one or more anchoring members that radially expand within a fusiform aneurysm. In some instances, the anchoring members radially expand to a diameter that is larger than that of regions of vessels adjacent to the fusiform aneurysm to help prevent stent migration. The anchoring members can be a bulbous layer, a plurality of loops, a plurality of arms, a plurality of longitudinal wires, or one or more hydrogel rings.